{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T04:41:37Z","timestamp":1649133697763},"reference-count":10,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["mdconsult.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.pupt.2013.12.004","type":"journal-article","created":{"date-parts":[[2014,1,5]],"date-time":"2014-01-05T04:31:01Z","timestamp":1388896261000},"page":"213-214","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Macrolide treatment in patients with bronchiectasis: More attention should be paid to the number of exacerbations"],"prefix":"10.1016","volume":"27","author":[{"given":"Yong-hua","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-jie","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong-chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"13","key":"10.1016\/j.pupt.2013.12.004_bib1","first-page":"00172","article-title":"Effectiveness and safety of macrolides in bronchiectasis patients: a meta-analysis and systematic review","volume":"S1094-5539","author":"Shi","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"issue":"12","key":"10.1016\/j.pupt.2013.12.004_bib2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.pupt.2013.12.004_bib3","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.pupt.2013.12.004_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.pupt.2013.12.004_bib5","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1183\/09031936.97.10050994","article-title":"Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study","volume":"10","author":"Koh","year":"1997","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.12.004_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1183\/09031936.99.13236199","article-title":"A pilot study of low-dose erythromycin in bronchiectasis","volume":"13","author":"Tsang","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pupt.2013.12.004_bib7","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00151829-200504020-00005","article-title":"The disease-modifying effects of twice-weekly oral azithromycin in patients with bronchiectasis","volume":"4","author":"Cymbala","year":"2005","journal-title":"Treat Respir Med"},{"key":"10.1016\/j.pupt.2013.12.004_bib8","doi-asserted-by":"crossref","unstructured":"Yao GY, Ma YL, Zhang MQ, Gao ZC. Macrolide therapy decreases chronic obstructive pulmonary disease exacerbation: a meta-analysis. Respiration 2013; (Article in press).","DOI":"10.1159\/000350828"},{"key":"10.1016\/j.pupt.2013.12.004_bib9","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.rmed.2013.05.004","article-title":"A meta-analysis on the prophylactic use of macrolide antibiotics for the prevention of disease exacerbations in patients with Chronic Obstructive Pulmonary Disease","volume":"107","author":"Donath","year":"2013","journal-title":"Respir Med"},{"key":"10.1016\/j.pupt.2013.12.004_bib10","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/jac\/dkr040","article-title":"Effectiveness and safety of macrolides in cystic fibrosis patients: a meta-analysis and systematic review","volume":"66","author":"Cai","year":"2011","journal-title":"J Antimicrob Chemother"}],"container-title":["Pulmonary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553913001995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553913001995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T12:51:38Z","timestamp":1538916698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553913001995"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1094553913001995"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2013.12.004","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrolide treatment in patients with bronchiectasis: More attention should be paid to the number of exacerbations","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2013.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}